Related Experiment Video
Updated: Jul 14, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Informatics and modeling challenges in fragment-based drug discovery
Roderick E Hubbard1, Ijen Chen, Ben Davis
1Structural Biology Laboratory, University of York, Heslington, York YO10 5YW, UK. r.hubbard@vernalis.com
Fragment-based drug discovery is a powerful method for identifying new drug candidates. Recent advancements focus on informatics and modeling, with ongoing opportunities for library diversity and binding prediction.
Area of Science:
- Drug discovery and development
- Computational chemistry
- Medicinal chemistry
Background:
- Fragment-based drug discovery (FBDD) is a successful structure-based approach.
- FBDD has led to drug candidates entering clinical trials.
- Significant progress has been made in FBDD methodologies.
Purpose of the Study:
- To review recent advancements in fragment-based drug discovery.
- To highlight the role of informatics and modeling in FBDD.
- To identify areas for future development in FBDD.
Main Methods:
- Literature review of recent developments in FBDD.
- Emphasis on informatics and computational modeling techniques.
- Analysis of strategies for fragment library design and evolution.
Main Results:
- FBDD is a validated strategy for hit generation and lead optimization.
- Informatics and modeling are crucial for FBDD success.
- Several FBDD projects have yielded clinical candidates.
Conclusions:
- Continued innovation in fragment libraries and binding mode prediction is needed.
- FBDD offers significant opportunities for novel drug development.
- Integration of computational tools enhances FBDD efficiency.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Overview

